✦ LIBER ✦

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

✍ Scribed by D'Addario, G.; Rauch, D.; Stupp, R.; Pless, M.; Stahel, R.; Mach, N.; Jost, L.; Widmer, L.; Tapia, C.; Bihl, M.; Mayer, M.; Ribi, K.; Lerch, S.; Bubendorf, L.; Betticher, D. C.

Book ID: 118008877
Publisher: Oxford University Press
Year: 2008
Tongue: English
Weight: 107 KB
Volume: 19
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdm564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab and erlotinib (BE) first-lin

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

✍ Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB

9147 Bevacizumab and erlotinib as first-

9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB

Gefitinib vs. chemotherapy as first-line

Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials

✍ Ku, Geoffrey Y.; Haaland, Benjamin A.; de Lima Lopes, Gilberto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

1307 POSTER First-line chemotherapy with

1307 POSTER First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study

✍ C. Tibaldi; E. Vasile; M. Lo Dico; A. Antonuzzo; R. Di Marsico; G. Tartarelli; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase III trial of docetaxel (D) and car

Phase III trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Giannakakis, Th; Mavroudis, D; Papadouris, S; Kourousis, Ch; Ziras, N; Kakolyris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 224 KB